TRIL Antikörper (AA 26-696)
Kurzübersicht für TRIL Antikörper (AA 26-696) (ABIN7600969)
Target
Alle TRIL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 26-696
-
Verwendungszweck
- Anti-TRIL Antibody
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Produktmerkmale
- Anti-TRIL Antibody (ABIN7600969). Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human TRIL recombinant protein (Position: V26-Q696).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Mouse, Rat
ELISA, 0.1-0.5 μg/mL, -
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- TRIL (TLR4 Interactor with Leucine-Rich Repeats (TRIL))
-
Andere Bezeichnung
- TRIL
-
Hintergrund
-
Synonyms: B-cell differentiation antigen CD72, Lyb-2, CD72, CD72
Tissue Specificity: Pre-B-cells and B-cells but not terminally differentiated plasma cells.
Background: KIAA0644, also known as TRIL or TLR4 interactor with leucine rich repeats, is a protein that in humans is encoded by the KIAA0644 gene. TRIL is a component of the TLR4 (603030) complex and is induced in a number of cell types by lipopolysaccharide (LPS).
-
Molekulargewicht
- 89 kDa
-
Gen-ID
- 9865
-
UniProt
- Q7L0X0
-
Pathways
- Activation of Innate immune Response, Production of Molecular Mediator of Immune Response
Target
-